"label","description","instanceType","identifier","id","uuid:ID","name","text"
"","The study age criterion","EligibilityCriterion","1","EligibilityCriterion_1","b7e1dcbc-bae3-4117-9538-fd1a69caddf0","Age Criteria","Subjects shall be between [min_age] and [max_age]"
"","The study population criterion","EligibilityCriterion","2","EligibilityCriterion_2","b70551d6-2313-4227-9852-88e192d09480","Pop Criteria","[StudyPopulation] as defined by the NINCDS and the ADRDA guidelines (Attachment LZZT.7)"
"","The study diagnosis criterion","EligibilityCriterion","3","EligibilityCriterion_3","01278b0a-e29d-4ba2-ab84-b29e5f73a734","Diag Criteria","[Activity1] score of 10 to 23"
"","The previous xanomeline TTS criterion","EligibilityCriterion","9","EligibilityCriterion_4","0bbd8ea4-9b71-4a9f-90d9-c6c65889f082","Previous Criteria","Persons who have previously completed or withdrawn from this study or any other study investigating xanomeline TTS or the oral formulation of xanomeline."
